A transgenic mouse line expressing the lacZ reporter under the control of a regulatory region of the col6a1 gene has been used to investigate differentiation of Schwann cells. The data suggest that: (1) activation of col6a1 gene transcription in the peripheral nervous system is part of the differentiation program of Schwann cells from neural crest cells stimulated by neuregulins; (2) once the Schwann cell precursors have acquired the competence of transcribing the col6a1 gene, transcriptional regulation becomes independent from neuregulins and is modulated by different mechanisms, including cell cycle; (3) activation of transgene expression after birth in sciatic nerves corresponds to the time of withdrawal of immature Schwann cells from the cell cycle and the beginning of their differentiation into myelinating Schwann cells. q
Introduction
Cells of developing peripheral nervous system (PNS) have a constant and intimate contact with the extracellular matrix and this interaction has been proposed to play important roles at various stages of differentiation Erickson and Perris, 1993) . Cells of the neural crest (NC) emerging from the neural tube come into contact with an extracellular matrix-rich environment synthesized by nearby embryonic tissues. The molecular composition of the matrix has been suggested to promote or inhibit NC cells movement and to determine the routes of their migration (Erickson and Perris, 1993) . NC cells give rise to various cell types in the PNS, including gangliar neurons, satellite and Schwann cells (SC) (Le Douarin et al., 1991) . The SC phenotype is particularly dependent on extracellular matrix. Thus, studies of co-cultures of SC and dorsal root ganglia neurons suggest that the ability of SC to proceed to myelination requires the assembly of a basal lamina . Formation of the basal lamina is also necessary for ensheathment of unmyelinated axons by SC (Obremski and Bunge, 1995) . An in vivo demonstration of the importance of the extracellular matrix in SC function comes from studies of inactivation of the laminin b2 chain, which is part of laminin-11, a component of the basal lamina of the neuro-muscular junction. Laminin-11 inhibits movement of SC and, in mice lacking the protein, the cytoplasmic protrusions of teloglia penetrate deeply into the synaptic cleft, thus altering the junction function (Patton et al., 1998) . In addition to NC a second type of embryonic tissue, the mesenchyme, contributes to cells of the PNS, giving rise to endoneurial and perineurial cells (Bunge et al., 1989) . These cells and SC are very active producers of extracellular matrix and molecules synthesized have been studied in some detail, especially for SC (Jaakkola et al., 1989; .
Collagen VI is a major component of pericellular matrix (Keene et al., 1988) . The molecule, a trimer of three different a-chains, is adhesive for different cell types and interacts with various constituents of the extracellular matrix including collagen IV, ®bronectin, hyaluronic acid, biglycan and decorin (Bidanset et al., 1992; Specks et al., 1992; Kuo et al., 1997) . In the mouse embryo, collagen VI expression is ®rst detectable at embryonic day (E) 10.5 at various locations, increases rapidly in the following days, is maintained at high levels during organogenesis and then decreases after birth . The protein is abundant in nerves, where it is produced both by SC and by endo-and perineurial cells (Jaakkola et al., 1989) . NC cells do not synthesize collagen VI, which is, however, a primary component of the extracellular matrix deposited along the NC migratory pathways, suggesting that the protein participates to the regulation of movement of this type of cells . Consistent with this hypothesis, in vitro assays comparing the biological activity of ®bronectin and collagen VI have revealed that the former component is a better substrate for NC cell adhesion, but the migratory response of these cells is higher on the latter . On the other hand, SC express collagen VI (Jaakkola et al., 1989) , indicating that they acquire this property at some stage during differentiation from the NC; how this process is regulated is, however, not known.
In a search for tissue-speci®c enhancers of the col6a1 gene, we derived transgenic mouse lines expressing the lacZ gene under the control of different portions of the 5 Hanking sequence of the col6a1 gene and identi®ed four cisacting regions regulating gene transcription in different tissues (Braghetta et al., 1996) . An enhancer region located at about 24.5 kb upstream the transcription start site drives transcription in the PNS, among other tissues (Girotto et al., 2000) . In these mouse lines the b-galactosidase marker is an indicator of the transcriptional activation of the col6a1 gene and can be exploited for addressing experimentally several questions on the spatio-temporal regulation of the gene during development. In this paper we have used a transgenic mouse line to analyze features of expression and to identify major mechanisms of regulation of the col6a1 gene in peripheral glia at different stages of development. The results show that: (1) activation of transcription of the col6a1 gene in the PNS is stimulated by neuregulins as part of the differentiation program of SC from NC cells; (2) once the SC precursors have acquired the competence of transcribing the col6a1 gene, transcriptional regulation becomes independent from neuregulins and is modulated by different mechanisms, including cell cycle; (3) after birth, activation of transgene expression in sciatic nerves coincides with withdrawal of immature SC from the cell cycle and the beginning of their differentiation into myelinating SC.
Results

Characterization of col6a1 transgene expression in the PNS
To analyze the temporal expression of the transgene in the PNS, embryos of the 7.5lacZ8 mouse line at different developmental stages were whole-mount stained with X-gal and with an antibody against neuro®laments (NF). Cells expressing the transgene were ®rst noted in the PNS at E11.5 associated with nerves growing into the forelimb bud (Fig. 1A) . At E12.5, X-gal 1 cells had increased considerably in number and could be detected in association not only with branches of nerves in the limb bud, but also with other spinal and cranial nerves (Fig. 1B) . At this stage of development, spinal nerves grow from their dorsal emergence ventrally into the body wall and distally into the limbs. This process was accompanied by the progressive appearance of nerve-associated X-gal 1 ; cells. Similarly, newly formed small collateral branches of nerves became also covered by lacZ expressing cells (Fig. 1C) . In all cases, X-gal 1 cells were never found distally to the nerve endings, but were detectable within a few diameters behind the distal tip of growing axon bundles (Fig. 1C,D, arrows) . This suggests that axons stimulated nearby cells to express the transgene. Careful examination of embryos from several transgenic mouse lines in addition to 7.5lacZ8 (Braghetta et al., 1996) , revealed the existence of a gradient of X-gal 1 cells increasing in the proximal-distal direction (data not shown). Quantitative evaluation of the phenomenon for the 7.5lacZ8 line is given in Table 1 , where two features of the transgene expression pattern can be noted. The ®rst is that the percentage of X-gal 1 nuclei reached a peak during development and then declined to a smaller constant value for each location, proximal or distal, a condition already detectable at E18.5 for the proximal sites. The second is that the amount of X-gal 1 cells was lower (2±4-fold) in proximal nervous trunks compared with the peripheral axon bundles at all ages examined, including adult mice, indicating that the gradient observed was not simply the consequence of a temporal difference of peak expression attainment at different sites.
Characterization of cells expressing the transgene
As mentioned in the Section 1, two cell lineages contribute to the formation of nerves, NC-derived SC and mesenchyme-derived endo-and perineurial cells (Bunge et al., 1989; Le Douarin et al., 1991) . To determine the association of transgene expression with either cell type, primary cultures were derived from sciatic nerves of newborn postnatal day (P) 2 transgenic mice and analyzed after maintenance in a de®ned serum-free medium. Cells were stained with X-gal and with antibodies which label SC, including anti-S 100 and low af®nity nerve growth factor receptor (LANGFR) (Jessen et al., 1994) . As summarized in Table 2 , SC (S100 1 cells) represented the majority of cells in 2-day cultures and 7% of them were blue; of the S100 2 cells, which can be considered of mesenchymal origin since at P2 all cells of the SC lineage produce this marker (Jessen et al., 1994) , 4% expressed the transgene. The deduced ratio of transgene expressing cells with and without the S100 marker was 6. When cells were cultured for only 5 h the amount of SC was higher, but the proportion of SC expressing the transgene remained constant. On the contrary, no X-gal 1 mesenchymal cells were detected in these conditions, indicating that expression of transgene by mesenchymal cells is very low in vivo and is turned on by culture conditions. Similar results were obtained using antibodies for the LANGFR. The conclusion suggested by these data is that most X-gal 1 cells in P2 nerves belong to the SC lineage.
Since transgene expression was apparent only in a frac-tion of SC, an obvious question was whether this represented cells that actually produced collagen VI. Cultures stained with X-gal and with antibodies against collagen VI showed that all SC had deposited collagen VI in their pericellular matrix after a few days in culture (data not shown). The fact that transgene expression was detectable only in a proportion of cells is explained by considering that collagen VI is deposited in the matrix in a stable form, while activation of its transcription and increase of mRNA levels are transient (see Section 3). Differentiation of SC progresses through several distinct stages that can be distinguished with different markers (Mirsky and Jessen, 1996; Zorick and Lemke, 1996) . Brie¯y, NC cells ®rst give rise to SC precursors, which later become immature (also called embryonic or committed) SC. These cells then progress into mature SC, which can be of either the myelin-forming or the non-myelin-forming variety. To identify the SC differentiation stage associated with col6a1 transgene expression, different experiments were performed either in vivo or in vitro. Expression of the transgene at initial stages of SC development was investigated by direct analysis on the peripheral nerve branches in the embryo. As expected from published data (Jessen et al., 1994; Dong et al., 1999) , the SC lineage at E13.5±E14.5 did not synthesize detectable amounts of S100 (data not shown), but expressed the LANGFR and cells of the SC line- Fig. 1 . Expression of the col6a1 transgene in developing peripheral nerves. E11.5 (A) and E12.5 (B±D) embryos were whole-mount stained for both X-gal and NF. First activation of the transgene was observed in association with axon bundles invading the forelimb bud (panel A, arrowheads). Blue cells were never found distally to the nerve endings, but were detectable starting from 1±2 nuclear diameters behind the distal tips of growing axon bundles (C,D, arrows).
age could be easily distinguished (Fig. 2) . Axon bundles, which also express the LANGFR, were very small in the periphery and their diameter was only a fraction of a nuclear diameter ( Fig. 2A,D) . Glial cells seemed to embrace the bundles of neurites, so that their abaxonal cytoplasm appeared as a thin, annular rim around the nucleus (Fig.  2B ). When sections were double stained with LANGFR and NF antibodies, this rim maintained a green¯uorescence, whereas axons appeared yellow, due to co-distribution of the two antigens (Fig. 2C) . Absence of S100 and presence of LANGFR have been proposed to be characteristics of SC precursors (Jessen et al., 1994) and these cells expressed the col6a1 transgene (Fig. 2D) .
A similar analysis was performed on sections from El8.5 embryos (data not shown), where transgene-expressing SC could be easily identi®ed due to their peculiar feature of cytoplasmic staining described above. At this later developmental stage, SC were positive both for S100 and LANGFR, but were negative for P 0 , a peripheral myelin protein expressed at high levels in myelin-forming SC (Lee et al., 1997) . Therefore, at this embryonic stage, cells expressing the transgene are still immature SC, given their staining features and in comparison with the analysis of SC differentiation performed in rat (Jessen et al., 1994 ) (see Section 3).
To better characterize expression of the transgene at the beginning of the myelination process, which starts at birth (Stewart et al., 1993) , SC were isolated from P2 sciatic nerves, allowed to adhere for a few hours and then stained with X-gal and by immuno¯uorescence for different antigens (LANGFR, GFAP (glial ®brillary acidic protein) and P 0 ). The short culture time was necessary to minimize the expression of P 0 taking place when SC are cultured in a de®ned medium (Cheng and Mudge, 1996) . The results of this analysis are shown in Fig. 3 and Table 3 . As it could be predicted for this stage of development, almost all SC expressed the LANGFR and GFAP markers. About one third of SC expressed P 0 , a ®nding which agrees very well with the percentage of P 0 positive cells evaluated at P2 in the rat in vivo (Stewart et al., 1993) and with the observation that LANGFR and P 0 are co-expressed in SC during the ®rst stages of myelination (Cheng and Mudge, 1996) . Surprisingly, however, all X-gal 1 cells expressed both LANGFR/ GFAP and P 0 , whereas the number of X-gal 1 cells producing only either type of marker was zero (Table 3) . As illustrated in Fig. 3 , both LANGFR and P 0 were coexpressed at the highest levels in all X-gal 1 SC, indicating that the cells were not modulating from a non-myelin-forming to a myelin-forming phenotype (or vice-versa). These data suggest that at birth, when myelination of SC begins, the transgene (i) is not expressed in cells with the immature phenotype (LANGFR 1 , GFAP 1 , P 0 2 ) and (ii) is expressed in cells which have undertaken the myelination process.
Effect of axonal signals on transgene expression
The morphological analysis of Fig. 1 , showing a tight association between axons and transgene producing cells, is suggestive of a stimulatory role of neurons or their a Note. Serial cryostat sections were treated by immuno¯uorescence for anti-NF to identify axon bundles, with X-gal to stain transgene-expressing nuclei and with Hoechst dye to mark all nuclei. The number of both total and X-gal 1 nuclei in contact with axons was determined in at least four different pictures. More than 300 and 100 nuclei were counted for the proximal and distal locations, respectively. Values represent the percentage of X-gal 1 over total nuclei^standard deviation. b The lumbosacral trunks of spinal nerves and sciatic nerves were considered as proximal locations for the embryonic and postnatal period, respectively. The small nerves of subepidermal mesenchyme of the ventral region of the abdomen were considered as distal location. Comment S100 1 cells/total cells £ 100 78^5 9 1 7 SC constitute the majority of cells in the preparation S100 2 cells/total cells £ 100 22^6 9 7
The proportion of mesenchymal cells increases with culture time S100
1 ,TG 1 cells/S100
The percentage of transgene 1 SC is constant and agrees with that of transgene 1 cells found in sections of sciatic nerves (see Table 1 ) S100 2 ,TG 1 cells/S100 2 cells £ 100 4^4 0 Transgene expressing cells of mesenchymal origin increase with culture time S100
1 ,TG 1 cells/S100 2 ,TG 1 cells 6 Very high c Most transgene 1 nuclei belong to SC a Note. Cells were isolated from sciatic nerves of newborn (post-natal day 2) transgenic mice, cultured for 2 days or 5 h and then processed for X-gal, immuno¯uorescence for S100 and Hoechst staining to determine the number of transgene positive (TG 1 ) cells, of SC and of total cells, respectively. The data at 2 days were deduced from three separate experiments and those at 5 h from two parallel samples in the same experiment. At least four different pictures from each individual sample were used for counting.
b Data at 2 days and 5 h were compared with the Student's t-test. c A numerical value could not be calculated due to the absence of S100 2 /TG 1 cells.
secreted molecules on col6a1 transgene transcription in the SC lineage. Since data in the literature indicate that NC cells do not produce collagen VI , an obvious stage of activation of the transgene would be the beginning of differentiation of NC cells along the SC lineage, a choice which is instructed by neuron-secreted neuregulins (Shah et al., 1994) . To verify this hypothesis we investigated the effect of neuregulins on NC cells derived from transgenic embryos ( Fig. 4 and Table 4 ). Transgene expression was absent in isolated neural tubes (data not shown) and very low in NC cells egressing from neural tubes overnight (Fig.  4A ). Two days after the removal of neural tube from the cultures, only a small fraction of NC-derived cells became X-gal 1 in control cultures (Fig. 4B) . However, the percentage of cells expressing the transgene was increased 13-fold in the presence of neuregulin after 2 days in culture (Fig. 4C Fig. 3 . col6a1 transgene expression in newborn SC cultures is associated with cells double positive for both LANGFR and P 0 . SC were isolated from sciatic nerves of P2 transgenic mice, allowed to adhere for 4 h and processed to reveal different markers. (A) LANGFR staining. (B) P 0 staining. (C) Double staining with X-gal and the nuclear Hoechst dye. Cells with nuclear X-gal staining (C, arrowheads) also strongly express the LANGFR and P 0 (arrows in A,B). Scale bar, 50 mm. Fig. 2 . Analysis of phenotypic markers of SC ®rst expressing the transgene in the embryo. Cryostat sections were prepared from E 13.5 embryos and stained with X-gal, antibodies against LANGFR and NF and with Hoechst dye. The same ®eld was observed for NF immuno¯uorescence (A), LANGFR immuno¯uorescence (B), double¯uorescence for NF and LANGFR (C) and for X-gal and Hoechst nuclear staining (D). Arrows in B and C point out the abaxonal cytoplasmic rim of SC, which is stained by antibodies against LANGFR, but not NF; the nuclei of these cells show a positive reaction for X-gal (D, arrowheads). Scale bar, 10 mm.
and Table 4 ). This proportion decreased slightly in the following days of culture.
To test whether there was an in¯uence of axon signals on transgene expression also at later differentiation stages, when immature SC differentiate into myelin-forming mature SC, primary cultures from sciatic nerves of P2 mice were incubated in the presence or absence of neuregulin for 2 days and the culture stained for X-gal and S100 (or GFAP). The percentage of X-gal 1 /S100 1 over total S100 1 cells was not signi®cantly different under the two conditions (3^1 and 5^2, respectively, P . 0:05). Extension of the incubation period up to 6 days did not alter this result. To check whether transgene expression was responsive to axonal contact or to signals released from axons other than neuregulin, SC were either cocultured with dorsal root ganglia from non-transgenic mice or grown in control conditions and the percentage of X-gal 1 /S100 1 over total S100 1 cells scored. Again, the difference was not signi®cant (15^4 and 10^3 in the presence and absence of dorsal root ganglia, respectively, P . 0:05).
These results indicate that col6a1 enhancer activation parallels the differentiation of SC from the NC under the in¯uence of axonal signals; in the subsequent process of SC differentiation, however, transgene expression is independent from these signals.
Correlation of transgene expression and SC proliferation at various differentiation stages
The above data prompted us to investigate additional mechanisms in¯uencing transgene expression during SC differentiation, besides axonal signals. Several studies demonstrated that collagen VI expression is highly in¯u-enced by cell proliferation in myoblasts (Ibrahimi et al. 1993; Piccolo et al., 1995) , ®broblasts (Hatamochi et al., 1989) , chondrocytes (Quarto et al., 1993) and adipocytes (Dani et al., 1989) . Therefore, we investigated the correlation between transgene expression and entry into the cell cycle by labeling nerve cells in the S-phase with 5-bromo-2 H -deoxyuridine (BrdU). This parameter was investigated both in embryos at two different ages (Table 5 ) and in cultures derived from P2 sciatic nerves (Table 6 ). From 14.5 to 18.5 days of gestation, the number of BrdU 1 cells in peripheral nerves decreased considerably (about 4-fold), indicating a lower proliferation rate in older embryos; in the same period the number of BrdU 1 /X-gal 1 cells dropped more dramatically (15-fold). Most important, the percentage of cells positive simultaneously for both markers was significantly lower than the one expected for a random distribution of each individual marker in the cell population at E18.5, but not at E14.5 (Table 5 ). This result suggests that at E18.5 cells expressing the transgene have a reduced proliferation rate. No BrdU 1 /X-gal 1 SC were scored in cultures from sciatic nerves of newborn mice, a result which was also statistically signi®cant (Table 6 ). This experiment strongly favors the view that newborn SC express the transgene when they stop proliferation.
Discussion
The results described in this report should be considered in the light of our present knowledge on the differentiation of the SC lineage. In vitro and gene inactivation studies have shown that SC originate from NC cells under the instructive effect of neuregulins released from migrating nerve terminals (Shah et al., 1994; Meyer and Birchmeier, 1995) . The use of different markers has identi®ed distinct intermediate stages in this differentiation process (Jessen et al., 1994; Dong et al., 1995; Mirsky and Jessen, 1996; Zorick and Lemke, 1996) . By adapting for mouse development the staging proposed for the rat (Jessen et al., 1994; Mirsky and Jessen, 1996 ) the following progression is obtained. The ®rst distinguishable phenotype in the pathway is called SC precursor which, in large nerve trunks, should predominate from about El 1.5±12.0 to E13.5±E14.5. From this embryonic age to E16.5 these cells modulate to immature (also called embryonic or committed) SC which are prevalent in the prenatal period and are characterized by S100 and The transgene is expressed only by SC at the beginning of the myelination process
The transgene is expressed only by SC at the beginning of the myelination process a Note. Cells were isolated from sciatic nerves of newborn (post-natal day 2) transgenic mice, cultured for 4 h and processed for X-gal, immuno¯uorescence for LANGFR and P 0 and Hoechst staining. SC were identi®ed on the basis of features distinguishing SC nuclei from those of mesenchymal cells (Obremski et al., 1993) .
GFAP expression and undetectable staining for P 0 . Finally, after birth, immature SC differentiate into mature SC which undergo the myelination process. Considering this pathway of SC differentiation, our results suggest the following three conclusions:
1. transcription of the col6a1 gene in the PNS requires a speci®c enhancer (Braghetta et al., 1996; Girotto et al., 2000) , whose activation is part of the differentiation program of SC from NC cells stimulated by neuregulins; 2. once the SC precursors have acquired the competence of transcribing the col6a1 gene, transcriptional regulation becomes independent from neuregulins and is modulated by different mechanisms, including cell cycle; 3. activation of transgene expression after birth in sciatic nerves corresponds to the time of withdrawal of immature SC from the cell cycle and the beginning of their differentiation into myelinating SC.
The ®rst conclusion is supported by some observations. One is that activation of the col6a1 transgene is an early event in SC differentiation, as indicated by the ®ndings that X-gal 1 cells were usually found only a few nuclear diameters behind axon terminals, and that LANGFR 1 /S100 2 blue cells were identi®ed in sections at E12.5±E14.5. We have tried to determine the identity of these cells by investigating the expression of GAP43, which would distinguish NC cells from SC precursors (Jessen et al., 1994; Dong et al., 1999) ; unfortunately, the two available antibodies against the mouse protein did not work in the conditions required in our experiments. However, on the basis of the embryonic period and the fact that freshly isolated NC cells do not express the transgene, these early X-gal 1 cells are, very likely, SC precursors. Another observation is that cultured NC cells expressed the col6a1 transgene at very low levels and that stimulation with neuregulin increased dramatically transgene activity within 2 days. We interpret this result as the induction of glial differentiation and not as the consequence of the expansion of a cell population stimulated by neuregulin. In fact, X-gal 1 cells were homogeneously and not clonally distributed in the cultures and visual evaluation could clearly exclude higher rates of cell division in this a Note. NC cells were isolated as detailed under Section 2, neuregulin (human recombinant HRGb1) or the corresponding buffer added after removal of the neural tubes and cells incubated for the indicated times. The cultures were then processed for X-gal, immuno¯uorescence for LANGFR and NF and Hoechst dye staining. NC-derived cells were identi®ed on the basis of their positive reaction for LANGFR and negative staining for NF (Shah et al., 1994) .
b The data represent the mean of two experiments in which values differed for less than 10%.
condition. It is interesting to note that NC stem cells cultures exposed to neuregulin for a similar time undergo inhibition of their neurogenic potential and are forced into the SC differentiation pathway (Shah and Anderson, 1997) . Thus, col6a1 transgene expression may constitute an early marker of commitment of NC stem cells to the glial fate during colonization of embryonic tissues by nerve terminals. A corollary of this proposal is that NC stem cells must be present in nerves several days after NC cells migration from the neural tube has ended. This condition has been demonstrated experimentally in a recent publication by Anderson and colleagues (Morrison et al., 1999) , who detected the presence of multipotent NC stem cells in rat sciatic nerves at E14.5±E17.5 (corresponding to E13±E16 in the mouse).
The second conclusion is strongly supported by the observation that, once started in the embryo, maintenance of transgene expression is not signi®cantly dependent on axonal signals, as documented by experiments in which newborn SC were cultured in the presence or absence of either neuregulins or dorsal root ganglia. This result also tells us that the col6a1 gene is not a direct target of neuregulin action. The expression of such a gene would have been more dependent on the presence of the growth factor, as described for the Krox20 gene under experimental conditions very similar to those used in this study (Murphy et al., 1996) . Therefore, our results indicate that stimulation of NC cells by neuregulins turns on the SC differentiation program, including the acquisition of transcriptional competence for the col6a1 gene, and that subsequent col6a1 gene transcription is modulated through additional mechanisms.
The third conclusion is less straightforward and is derived from the following considerations:
1. Collagen VI expression is strongly dependent on the cell cycle. This property is still not understood at the molecular level, but has been consistently observed in several cellular systems (Dani et al., 1989; Hatamochi et al., 1989; Ibrahimi et al., 1993; Piccolo et al., 1995) . In culture, collagen VI expression is low in proliferating cells and at low cell density. When cell proliferation decreases and the cell density increases, collagen VI expression is enhanced. At con¯uence or when proliferation is prevented by drugs which block the cell cycle, the levels are maximized. It is important to note that this increase is transient and that expression becomes again low after the cells become quiescent. Expression of a transgene similar to that studied here, but with a CAT instead of a lacZ reporter gene (Braghetta et al., 1997) , has been found to conform to the same rules in ®broblasts (P. Vitale, unpublished results). Thus, activation of the transgene appears to correspond with the time of exit of cells from the cell cycle to become quiescent. This behavior explains why several cell types, including myoblasts (Ibrahimi et al. 1993; Piccolo et al., 1995) , chondrocytes (Quarto et al., 1993) , adipocytes (Dani et al., 1989) and SC (P. Vitale, unpublished results) exhibit a transient burst of collagen VI expression when they stop dividing and differentiate. a Note. Embryos were dissected from pregnant females after injection of BrdU and frozen in liquid nitrogen. Cryostat sections were prepared and stained with Hoechst dye, X-gal and by immuno¯uorescence with antibodies against BrdU and NF. Cells were counted in areas of lumbosacral trunks of spinal nerves positive for NF and at least four different microscopic ®elds were considered. Consequently the measurements include the contribution of both SC and mesenchymal cells; the latter should, however, be very limited (see Table 2 for P2 mice).
b The measured percentage of BrdU 1 /X-gal 1 was compared with that for each marker separately, assuming a random distribution of staining in the cell population and using the x 2 parameter with the Yates correction for a two-variable determination. a Note. Cells were isolated from sciatic nerves dissected from newborn (post-natal day 2) mice, allowed to adhere shortly to the slides, incubated in the presence of BrdU for 1 h, ®xed and stained with X-gal, antibodies against LANGFR or GFAP and Hoechst dye. Only SC, identi®ed by either LANGFR or GFAP antibody staining, were considered. The percentage of SC measured with either LANGFR or GFAP antibody was very similar. The data were obtained in four separate experiments and at least four pictures from each sample were used for cell counting.
b The measured percentage of BrdU 1 /X-gal 1 was compared with that expected for each marker separately assuming a random distribution of staining in the cell population and using the x 2 parameter with the Yates correction for a two-variable determination.
2. Cell cycle dependence of collagen VI expression by SC is acquired during development. In fact, BrdU labeling experiments indicate that, in E14.5 embryos, transgene expression is randomly distributed in proliferating and non-proliferating cells. We interpret this result as a consequence of the fact that the predominant process at this age is differentiation of NC cells into SC precursors, which induces high transcriptional activity of the col6a1 gene (see above). At E18.5, cells expressing the transgene are not undergoing replication. These cells show dependence of col6a1 expression on the cell cycle (Table 5 ) and very likely represent immature SC which cease dividing and become quiescent. 3. Transgene expression in newborn mice is detectable only in non-replicating SC labeled with both LANGFR (or GFAP) and P 0 . The differentiation of myelinating SC from immature SC is accompanied by variation of expression of different markers. Immature SC are LANGFR
, whereas mature SC are LANGFR 2 /GFAP 2 / P 0 1 (Mirsky and Jessen, 1996; Zorick and Lemke, 1996 ). An intermediate cell phenotype (LANGFR 1 /GFAP 1 / P 0 1 ) is also observed. These markers characterize cells at the beginning of the differentiation process. As differentiation proceeds the cells loose expression of LANGFR and GFAP and maintain production of P 0 , thus acquiring the phenotype of mature SC. The three differentiation stages, from now on indicated as immature, intermediate and mature SC, have peculiar properties as far as proliferation and col6a1 transgene expression is concerned. BrdU and X-gal labeling of E18.5 embryos shows that immature SC can proliferate and that proliferating cells do not express the transgene. On the other hand, it is known from the literature that P 0 1 cells, which include intermediate and mature SC, do not proliferate in vivo (Stewart et al., 1993) . This result has been con®rmed in our in vitro experiments with post-natal cell cultures, which, in addition, show that transgene expression is detectable only in intermediate, but not in mature SC. It is therefore clear that immature SC undertaking the differentiation process stop dividing, acquire the intermediate phenotype (LANGFR 1 /GFAP 1 /P 0 1 ) and express the transgene. Once SC acquire the mature phenotype (LANGFR 2 /GFAP 2 /P 0 1 ) they maintain the quiescent state, but no longer express the transgene.
The above considerations imply that transgene expression is associated only with SC which have just begun the differentiation process. Thus, our analysis may have unveiled a speci®c step of SC differentiation in postnatal nerve development: the actual undertaking by immature SC of terminal differentiation into myelinating SC. Given the transient expression of collagen VI induced by inhibition of proliferation, col6a1 transgene appearance would just identify this speci®c initial step and not the whole differentiation process, which is marked by persistent P 0 and inhibition of LANGFR and GFAP expression. As a consequence, only a small proportion of SC is expected to express the transgene in vivo and this may well correspond to the percentage (about 5%) measured in myelinating nerves in postnatal life (Tables 1 and 5) .
Continuous gradients of collagen VI expression, such as that described here for the col6a1 transgene along nerves, have been found in epiphysial cartilage (decreasing form the articular surface inwards) and in connective tissue underneath several epithelia (decreasing from the basement membrane toward interstitial tissue) (Quarto et al., 1993; Marvulli et al., 1996) . How these gradients are established is still unknown. One attractive hypothesis is that gradients of collagen VI expression are related to differences in growth factor activities, which determine the proliferation and the differentiation properties of the cells. In addition to neuregulins, several other growth factors, like factors of the TGF-b superfamily, IGFs and FGF-2, are known to be active on SC and it has been proposed that the regulation of their activity may vary along the nerves (Mirsky and Jessen, 1996; Zorick and Lemke, 1996) .
In summary, the data described here have identi®ed important regulatory steps of col6a1 gene transcription in the PNS and provided preliminary information on the mechanisms involved. The enhancer required for acquisition of transcriptional competence in SC is located at about 24.5 kb from the col6a1 transcription start site (Braghetta et al., 1996; Girotto et al., 2000) . The region mediating cell cycle dependence of transcription probably corresponds to that with a similar function in myoblasts and ®broblasts, which lies close to the core promoter (Piccolo et al., 1995; Fabbro et al., 1999; P. Vitale, unpublished results) . Further information on the mechanisms regulating col6a1 gene transcription during differentiation of SC will likely be obtained through the characterization of these two cis-acting regions and the identi®cation of the transcription factors binding to them.
Experimental procedures
Transgenic animals. The 7.5lacZ8 mouse line, in which 7.5 kb of 5 H -¯anking region of the col6a1 gene drive expression of a nuclear form of the E. coli lacZ gene was used throughout (Braghetta et al., 1996) . 7.5lacZ8 males were crossed with CD1 females and transgenic embryos (day of vaginal plug E0.5) or born individuals of various age were variously processed depending on the type of experiment. Transgenic animals were identi®ed by performing Xgal staining on tail biopsies or on appropriate parts of the body as detailed below in the various experiments. All animal manipulations conformed to the rules of the ethic committee of the University of Padova.
Primary cultures of SC from sciatic nerves
Two-day-old newborn mice were killed with ether and transgenic individuals identi®ed by staining tail biopsies with X-gal at 378C for 15 min. During this time the body was kept on ice. The animals were then sterilized by rapid submersion in ethanol, the sciatic nerves dissected under a stereo-microscope and stored in cold phosphate buffered saline (PBS) until used. The nerves were carefully cleaned from the surrounding connective tissue, ®nely minced and digested for 1 h at 378C in Dulbecco modi®ed Eagle's medium (DMEM) containing 2 mg/ml collagenase (Worthington), 1.2 mg/ml hyaluronidase (Sigma), 0.3 mg/ ml ovomucoid trypsin inhibitor (Sigma) and 0.6 mM EDTA with occasional trituration. The reaction was blocked by addition of an equal volume of DMEM containing 10% fetal calf serum (FCS) and the sample centrifuged for 10 min at 500 £ g. The cell pellet was resuspended in de®ned medium (Jessen et al., 1994) , recentrifuged, taken up in the same medium and plated (5±10 £ 10 3 cells/0.2 ml) into 1-cm 2 -wells Chamber slides (Nunc), which were previously coated with poly-l-lysine (20 mg/ml for 12 h at 378C) and laminin (20 mg/ml for 2 h at room temperature). The cells were incubated at 378C in a 5% CO 2 atmosphere and the medium changed after 12 h and each other day. When needed, recombinant human neuregulin [rHRGb1 177±244 , a fragment of heregulin b1 (HRGb1)] (Genentech) was added at 10 nM. At the end of the experiment the slides were washed with PBS, air dried and stored at 2808C until used for staining.
Co-cultures of dorsal root ganglia and SC
Dorsal root ganglia were dissected from non-transgenic EI2.5 embryos generated by CD1 £ CD1 crossing and transferred into 24 well plates (6 ganglia/well) previously coated with collagen I. For coating, each well was incubated with a solution of 20±30 mg/ml collagen I from rat tail in PBS for 24 h at 378C and washed three times with PBS before use. The ganglia were cultured in 0.2 ml/well DMEM containing 5% FCS, 5% horse serum, 5 mg/ml insulin and 100 mg/ml nerve growth factor (NGF) at 378C in 5% CO 2 (Jessen et al., 1994) . After 24 h the medium was changed with one containing, in addition, 10 26 M cytosine arabinoside. The ganglia were incubated for 2 days in this medium and then for 2 days in medium without cytosine arabinoside. This treatment was repeated twice more and was required to prevent growth of cells (®broblasts and satellite cells) contaminating the dorsal root ganglia preparations. A few hours before addition of SC derived from transgenic embryos (see above), the medium was changed with a de®ned medium for SC containing 100 mg/ml NGF (Jessen et al., 1994) . After addition of SC, the co-culture was incubated in the same medium for 2 days. Finally, the samples were washed with PBS, air dried and stored at 2808C before staining.
Cultures of NC cells
E9.5 embryos generated by 7.5lacZ8 £ CD1 crossing were dissected and transferred into Hank's balanced salt solution, pH 7.3, maintained in an ice bath. The trunk region corresponding to the last 10 somites was dissected out with tungsten needles from embryos with less of 26 somites, whereas the anterior part of the body was processed for X-gal staining to identify transgenic individuals. At this stage of development, mesenchymal tissues of the neck region and the dorsal aorta express the transgene and the staining reaction takes usually 20±30 mm. The trunk regions were digested in groups of 5±6 with a solution of 0.25% trypsin (Worthington) in Hank's solution for 12 min at 48C. The reaction was stopped by transferring the samples into DMEM with 10% FCS and the neural tubes released from the surrounding tissues by mild trituration. The neural tubes were then plated on ®bronectin-coated 35 mm Petri dishes (0.5 ml human ®bronectin at 10 mg/ml in Na bicarbonate (pH 9.6), for 12 h at 48C, then washed with DMEM before use) containing 0.5 ml of the de®ned medium for NC cells described by Rao and Anderson (1997) . After incubation for 1 h at 378C in 5% CO 2 . when the neural tubes had attached to the dish, 1 ml of de®ned medium was carefully added. Two days later the neural tubes were removed with a tungsten needle, the medium changed and incubation of NC cells migrating out from the neural tubes extended for up to 5 days, with medium change each other day. Some samples were grown in the presence of 10 nM HRGb1 (Genentech) (Shah et al., 1994) . The cultures were ®nally washed with PBS, air dried and stored at 2808C before processing for staining reactions.
4.4. Whole-mount staining of embryos for b -galactosidase and neuro®laments (NF) E9.5±l5.5 embryos were stained with X-gal, ®xed for 12± 16 h in 4% paraformaldehyde in PBS and stored at 2208C in methanol. Staining for NF was performed with mouse monoclonal antibody iC8 (Vitadello and Denis-Donini, 1990) , with a protocol adapted from Meyer and Gruss (1993) . The embryos were cleared for 2 h in a solution composed of two parts methanol and one part 30% H 2 O 2 , rehydrated by incubation twice for 30 min in TBST buffer (10 mM Tris±HCl (pH 7.0), 150 mM NaCl, 0.05% Tween 20) and incubated for 12 h at 48C with the iC8 antibody diluted at 1±2 mg/ml in blocking solution (80% heat-inactivated FCS and 20% TBST). The embryos were then washed ®ve times for 1 h in TBST and incubated for 12 h at 48C with peroxidase-conjugated goat anti-mouse Ig (Sigma) diluted 1:100 in blocking solution. After thorough washing in TBST (®ve times for 1 h) the immunological reaction was revealed using a procedure adapted from Jones et al. (1995) , in which the black stained regions are better distinguished against the white background. Embryos were incubated for a few minutes in 50 mM Tris±HCl, pH 7.5, containing 0.5 mg/ ml diaminobenzidine, 0.1% H 2 O 2 and 0.64% NiCl 2 and the reaction stopped by washing in PBS. Pictures were taken with a camera-equipped stereo microscope and the embryos were stored in 75% glycerol in PBS.
Staining of tissue sections and cell cultures
Sections were cut from E12.5 to E18.5 embryos and P2± P33 transgenic mice. After dissection, embryos were immediately frozen in melting isopentane. Animals were killed with ether and tissues of interest dissected and similarly frozen. In each case a tail biopsy was taken to identify transgenic individuals after X-gal staining. Sections (6 mm thick) were cut in a cryostat, taken up on gelatin subbed slides, air dried and stored at 2808C. Slides with sections or with cultured cells were ®xed in 4% paraformaldehyde in PBS for 5 min, stained for 4±8 h with X-gal at 378C and washed with PBS. After treatment with 10% goat serum in PBS for 20 min, the slides were incubated with primary antibodies diluted in 5% goat serum in PBS for different times and temperatures depending on the antibody. The samples were then washed in PBS and incubated with the appropriate secondary antibodies, washed again, stained for 5 mm in Hoechst dye solution (5 mg/ml in PBS) and mounted in 75% glycerol in PBS. Primary antibodies used included: rabbit polyclonal to bovine S100 (Sigma), dilution 1:100, incubation for 12 h at room temperature; rabbit polyclonal to mouse LANGFR (low af®nity nerve growth factor receptor) (Chemicon), dilution 1:200, incubation for 12 h at room temperature; rabbit polyclonal to cow GFAP (glial ®brillary acidic protein) (Dako), dilution 1:200, incubation for 12 h at 48C; rabbit polyclonal to mouse collagen VI (provided by Dr A. Colombatti) dilution 1:100, incubation for 1.5 h at room temperature (Colombatti et al., 1992) ; mouse monoclonal antibody iC8, raised against mouse NF (a gift of Dr M. Vitadello), working concentration 1-2 mg/ ml, incubation for 1.5 h at room temperature (Vitadello and Denis-Donini, 1990 ); mouse monoclonal antibody P 0 7 which recognizes rodent and human P 0 (gift of Dr Juan Jose Â Archelos), working concentration 20 mg/ml, incubation for 1.5 h at room temperature (Archelos et al., 1993) . Secondary antibodies (Sigma) were incubated for 1 h at room temperature at a dilution of 1:200 in 5% goat serum in PBS and included: biotinylated goat anti-rabbit 1g. followed by peroxidase-or FITC-conjugated Extravidin (Sigma), and peroxidase-or TRITC-conjugated goat antimouse Ig.
X-gal staining
The procedure followed was exactly that described by Bonnerot and Nicolas (1993) .
Labeling of animal tissues and cell cultures with 5-bromo-2
H -deoxyuridine (BrdU)
Pregnant mice were injected intraperitoneally with 0.2 ml of 5 mg/ml BrdU in PBS and sacri®ced after 1 h. Transgenic embryos were identi®ed by X-gal staining, frozen and cryostatic sections prepared as described above. Cells isolated from the sciatic nerve from P2 mice were allowed to adhere to chamber slides for 4 h and labeled in serum-free medium (see above) containing 5 mg/ml BrdU. After washing with PBS the slides were air dried and processed for X-gal staining. Slides containing either tissue sections or cells were sequentially ®xed in 10% paraformaldehyde in PBS for 5 min, incubated for 20 min in 2N HCl, treated with 10% goat serum in PBS for 20 min, processed for anti-BrdU staining using the`BrdU labeling and detection Kit I' (Boehringer Mannheim) following the procedure recommended by the manufacturer and a 1:3 instead of a 1:10 dilution of the antiBrdU monoclonal antibody and with FITC-labeled antimouse Ig for 30 min. Finally the slides were washed and stained with different antibodies (anti-NF, anti-LANGFR, anti-GFAP) as detailed above.
